+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades



Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades



Cancer 119(15): 2720-2727



Acute myeloid leukemia (AML) is the common form of acute leukemia in adults, accounting for over 80% of all acute leukemias in individuals aged >18 years. Overall 5-year survival remains poor in older AML patients; it is <5% in patients aged >65 years. In this study, the authors examined whether survival has improved for subsets of geriatric AML patients over 3 successive decades. Surveillance, Epidemiology and End Results (SEER) data were used to determine trends in relative survival by age among 19,000 patients with AML over 3 successive decades (1977-1986, 1987-1996, and 1997-2006). Relative survival rates (RRs) with 95% confidence intervals (CIs) were calculated as measures of survival. Overall, the RRs increased for each successive decade (1977-1986, 1987-1996, and 1997-2006) in patients ages 65 to 74 years, with improvements in 12-month survival from 20%, to 25%, to 30%, respectively. Findings were similar for 24-month, 36-month, 48-month, and 60-month survival. However, survival rates did not improve in patients aged ≥75 years. The oldest old patients (aged ≥85 years) had the lowest survival rates, with no apparent improvement. This analysis of a large data set demonstrated that, although overall survival remained unsatisfactory among older patients, it improved in the younger old (ages 65-74 years). Survival of older old AML patients has not been favorably impacted by available AML therapies or supportive care, and intervention in this age group is best undertaken on a clinical trial.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054808711

Download citation: RISBibTeXText

PMID: 23633441

DOI: 10.1002/cncr.28129


Related references

Linking Costs and Survival in the Treatment of Older Adults With Chronic Myeloid Leukemia: An Analysis of SEER-Medicare Data From 1995 to 2007. Medical Care 54(4): 380-385, 2016

Socioeconomic status (SES) and childhood acute myeloid leukemia (AML) mortality risk: Analysis of SEER data. Cancer Epidemiology 44: 101-108, 2016

Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001-2013. Acta Haematologica 139(2): 115-127, 2018

Burden of Acute Myeloid Leukemia Among Older, Newly Diagnosed Patients: Retrospective Analysis of Data From the 2010-2012 Medicare Limited Data Set. Clinical Therapeutics 40(5): 692-703.E2, 2018

Prognostic nomogram for adult patients with acute myeloid leukemia: A SEER database analysis. Medicine 98(21): E15804, 2019

Characterization and analysis of the outcome of adults with acute myeloid leukemia treated in a Brazilian University hospital over three decades. Brazilian Journal of Medical and Biological Research 44(7): 660-665, 2011

Treatment Patterns and Outcomes among Elderly Patients with Chronic Myeloid Leukemia An Analysis of Linked SEER-Medicare Data. Blood 100(11): Abstract No 3450, 2002

Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup. Haematologica 92(6): 763-770, 2007

Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup. Journal of Clinical Oncology 22(18): 3741-3750, 2004

Prophylactic Growth Factor Use in Older Patients with Previously Untreated Acute Myeloid Leukemia A Published Data Meta-Analysis. Blood 100(11): Abstract No 2213, 2002

Mortality and Vascular Events Among Elderly Patients With Chronic Myeloid Leukemia: A Retrospective Analysis of Linked SEER-Medicare Data. Clinical Lymphoma Myeloma and Leukemia 16(5): 275-285.E1, 2016

Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup. Journal of Clinical Oncology 27(18): 3000-3006, 2009

Outcome of older patients with acute myeloid leukemia in first relapse. American Journal of Hematology 88(9): 758-764, 2013

Population-based disparities in survival among patients with core-binding factor acute myeloid leukemia: a SEER database analysis. Leukemia Research 38(7): 773-780, 2014

Improvements in the early death rate among 9380 patients with acute myeloid leukemia after initial therapy: A SEER database analysis. Cancer 121(12): 2004-2012, 2015